Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02283359
Title Selinexor in Combination With Irinotecan in Adenocarcinoma of Stomach and Distal Esophagus
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors H. Lee Moffitt Cancer Center and Research Institute
Indications

esophagus adenocarcinoma

gastroesophageal junction adenocarcinoma

gastric adenocarcinoma

Therapies

Irinotecan + Selinexor

Age Groups: adult
Covered Countries USA


No variant requirements are available.